Annual Shareholders Equity
$24.47 M
-$15.78 M-39.19%
31 December 2023
Summary:
Cognition Therapeutics annual stockholders equity is currently $24.47 million, with the most recent change of -$15.78 million (-39.19%) on 31 December 2023. During the last 3 years, it has fallen by -$26.80 million (-52.27%). CGTX annual shareholders equity is now -52.27% below its all-time high of $51.27 million, reached on 31 December 2021.CGTX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$14.48 M
-$8.53 M-37.06%
30 September 2024
Summary:
Cognition Therapeutics quarterly stockholders equity is currently $14.48 million, with the most recent change of -$8.53 million (-37.06%) on 30 September 2024. Over the past year, it has dropped by -$9.99 million (-40.83%). CGTX quarterly shareholders equity is now -71.76% below its all-time high of $51.27 million, reached on 31 December 2021.CGTX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CGTX Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -40.8% |
| 3 y3 years | -52.3% | -71.8% |
| 5 y5 years | +141.9% | - |
CGTX Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -52.3% | at low | -71.8% | at low |
| 5 y | 5 years | -52.3% | +135.9% | -71.8% | +116.7% |
| alltime | all time | -52.3% | +135.9% | -71.8% | +116.7% |
Cognition Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $14.48 M(-37.1%) |
| June 2024 | - | $23.01 M(-20.3%) |
| Mar 2024 | - | $28.86 M(+17.9%) |
| Dec 2023 | $24.47 M(-39.2%) | $24.47 M(-15.4%) |
| Sept 2023 | - | $28.93 M(-15.9%) |
| June 2023 | - | $34.39 M(-3.9%) |
| Mar 2023 | - | $35.78 M(-11.1%) |
| Dec 2022 | $40.25 M | $40.25 M(+2.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $39.32 M(-10.4%) |
| June 2022 | - | $43.90 M(-9.9%) |
| Mar 2022 | - | $48.74 M(-4.9%) |
| Dec 2021 | $51.27 M(-175.2%) | $51.27 M(-159.1%) |
| Sept 2021 | - | -$86.72 M(+3.6%) |
| June 2021 | - | -$83.68 M(+23.3%) |
| Mar 2021 | - | -$67.85 M(-0.5%) |
| Dec 2020 | -$68.18 M(+16.7%) | -$68.18 M |
| Dec 2019 | -$58.42 M | - |
FAQ
- What is Cognition Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Cognition Therapeutics?
- What is Cognition Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Cognition Therapeutics?
- What is Cognition Therapeutics quarterly shareholders equity year-on-year change?
What is Cognition Therapeutics annual stockholders equity?
The current annual shareholders equity of CGTX is $24.47 M
What is the all time high annual shareholders equity for Cognition Therapeutics?
Cognition Therapeutics all-time high annual stockholders equity is $51.27 M
What is Cognition Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of CGTX is $14.48 M
What is the all time high quarterly shareholders equity for Cognition Therapeutics?
Cognition Therapeutics all-time high quarterly stockholders equity is $51.27 M
What is Cognition Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, CGTX quarterly stockholders equity has changed by -$9.99 M (-40.83%)